髂动脉分叉覆膜支架重建(CERIB)技术的中期结果
BACKGROUND: The aim of this study is to present the 30-day and mid-term outcomes of the off-the-shelf covered endovascular reconstruction of iliac bifurcation (CERIB) technique in patients managed with endovascular repair for aortoiliac aneurysms.…
要点
- CERIB技术用于主髂动脉瘤血管腔内修复,技术成功率100%。
- 12个月通畅率98%,6个月免于沟槽型内漏Ib率96.8%。
- 6个月免于再干预率93.8%,中期随访无额外事件。
核心结论
- CERIB技术治疗复杂主髂动脉病变技术成功率高、通畅率良好、早期并发症和再干预率低,中期结果持久。
研究设计与样本
- 单中心回顾性分析纳入2022年12月至2025年12月接受CERIB技术的主髂动脉瘤患者59例,共78例CERIB手术(19例双侧)。
主要发现
- 平均随访12±7个月,发生1例癌症相关死亡(1.7%;1/57)。
- 12个月通畅率估计为98%(标准误2%),随访期间无进一步事件。
- 6个月免于沟槽型内漏Ib率为96.8%(标准误2.2%),随访期间无进一步事件。
- 6个月免于再干预率为93.8%(标准误3%),随访期间无进一步事件。
临床怎么用
- 对于适合腔内修复的主髂动脉瘤患者,CERIB技术可作为处理髂动脉分叉病变的选项,需关注内漏和再干预风险。
局限性
- 单中心回顾性设计,样本量有限(59例),随访时间较短(平均12个月)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The aim of this study is to present the 30-day and mid-term outcomes of the off-the-shelf covered endovascular reconstruction of iliac bifurcation (CERIB) technique in patients managed with endovascular repair for aortoiliac aneurysms. METHODS: A single-center retrospective analysis was conducted including patients with aorto-iliac aneurysms that received the CERIB technique from December 2022 to December 2025. Proximal repair of the aorta was performed either with standard endovascular aneurysm repair (EVAR) or complex EVAR. Mortality, patency, presence of endoleak (EL), and reinterventions were analyzed at 30 days and during mid-term period. RESULTS: Fifty-nine patients (mean age: 71.6 ± 6, 100% males) were included, receiving 78 CERIB procedures (19 bilaterally). Nineteen patients had previous endovascular aortic aneurysm repair and half of them (49%; 29/59) received primarily EVAR. The technical success was 100%. Two deaths (3,3%) were recorded in 2 fenestrated/branched endovascular aortic aneurysm repair (F/BEVAR) patients during 30-day postop period. The mean follow up was 12 ± 7 months, with one cancer-related death (1.7%; 1/57). Patency rate was estimated at 98% [standard error; (SE) 2%] at 12 months and remained the same with no further event during follow up. The freedom from gutter EL Ib rate was 96.8% (SE 2.2%) at 6 months and remained the same with no further event. The freedom from reintervention rate was 93.8% (SE 3%) at 6 months and remained the same with no further event. CONCLUSION: The CERIB technique represents an endovascular procedure for managing complex aorto-iliac pathology, with excellent technical success, favorable patency rates, low early complication and reintervention rates, and durable mid-term outcomes.
引用
- Matsagkas M, Nana P, Chaidoulis A, et al. Mid-Term Outcomes of 'Covered Endovascular Reconstruction of Iliac Bifurcation: The 'CERIB' Technique. Ann Vasc Surg. 2026. PMID: 42697321. doi:10.1016/j.avsg.2026.08.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。